Treatment
Medication clinical trials
We’re tracking 7,440 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07662655RecruitingEarly Phase 1
PADN for pulmonary hypertension after mitral valve repair
This study tests a new procedure called pulmonary artery denervation (PADN) to lower high blood pressure in the lungs that persists after a mitral valve repair. It aims to see if this extra treatment improves symptoms and outcomes for people with this condition.
Xiamen, FujianAges 18–80 - NCT07664579Recruiting
Couples coping together against cancer support program
This trial tests a supportive care program for couples facing cancer. It helps you and your partner work together to manage the challenges of a cancer diagnosis.
Duarte, CaliforniaAges 18 years+ - NCT07665658Recruiting
Supplements for ADHD: Calming brain inflammation in kids
This study tests whether special supplements can help calm inflammation in the brain and improve ADHD symptoms in children. It might be a good fit if your child's ADHD is diagnosed and they are not taking antibiotics or have other health issues like gut problems or severe allergies.
Peshawar, KPKAges 6–12 - NCT07668037Recruiting
Understanding long-term survival in NSCLC immunotherapy
This study looks at patients with advanced non-small cell lung cancer who received immunotherapy (immune checkpoint inhibitors) alone or in combination with other treatments. It aims to understand why some patients survive longer than others by analyzing their medical data and using AI to predict outcomes.
BeijingAges 18 years+ - NCT07668453RecruitingPhase 2
Adebrelimab plus chemo for advanced bile duct cancer
This study tests adding the immunotherapy adebrelimab to standard chemotherapy (gemcitabine and nab-paclitaxel) as a first treatment for advanced biliary tract cancer that can't be removed by surgery. The goal is to see if this combination helps shrink tumors and improve outcomes.
Nanjing, JiangsuAges 18–75 - NCT07669298Recruiting
Monitoring vs chemoradiation for early rectal cancer
This study compares two approaches after early-stage rectal cancer is removed: either careful monitoring or a follow-up treatment with chemotherapy and radiation. The goal is to see which strategy works better to keep the cancer from returning.
LimogesAges 18 years+ - NCT07669493Recruiting
Heart safety during chest radiation for cancer patients
This study looks at how chest radiation affects heart function and the immune system, and whether it is safe in people with lung, esophageal, breast, or thymus cancer who have not had chest radiation before.
Shijiazhuang, HebeiAges 18 years+ - NCT07670169Recruiting
How NOTCH2NLC gene changes affect NIID in one family
This trial studies a family with a gene change (NOTCH2NLC) that can cause NIID, a disease that affects nerves and the brain. It aims to understand how different gene variations relate to symptoms.
Chengdu, SichuanAges Any age - NCT07670273RecruitingPhase 2
Drug combo for advanced HER2 bile duct cancer
This trial tests a combination of three drugs (trastuzumab rezetecan, adebrelimab, and lenvatinib) as a first treatment for people with advanced HER2-positive or HER2-low bile duct or gallbladder cancer. The goal is to see if this combination helps shrink or control the cancer.
BeijingAges 18–75 - NCT07670234Recruiting
Dietary Supplements and Cancer Treatment
This study looks at how dietary supplements (like vitamins and herbs) affect cancer patients who are on treatment. It checks if supplements cause side effects, change how medications work, or interact with each other.
RabatAges 18 years+ - NCT07670286Recruiting
Spotting early warning signs of pancreatic cancer wasting
This study checks if advanced computer analysis of your tumor and body can predict severe weight loss and muscle wasting (cachexia) from pancreatic cancer. If you join, you may help doctors find earlier warning signs to improve treatment.
BeijingAges 18 years+ - NCT07671378RecruitingPhase 2
Study of zanubrutinib plus sonrotoclax for high-risk CLL/SLL
This trial tests a combination of two targeted drugs (zanubrutinib and sonrotoclax) as a first treatment for people with high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL). It aims to see if this approach works better than standard care by using a test called MRD to guide treatment duration.
Nanjing, JiangsuAges 18–75 - NCT07671898Recruiting
Freezing vs. Radiofrequency for Slow Heart Rate
This trial compares two procedures to treat very slow heart rates without needing a pacemaker. One uses freezing (cryoablation) and the other uses radiofrequency energy to target nerves that control heart rate.
Tomsk, Tomsk OblastAges 18–60 - NCT07672145Recruiting
Gallbladder removal: belly button vs. upper belly cut
This trial compares two ways to remove the gallbladder during laparoscopic surgery: through the belly button or through a cut just below the breastbone. It aims to find which method causes less pain and recovers faster.
Lahore, Punjab ProvinceAges 18–60 - NCT07672275Recruiting
How blood transfusions affect stress markers in newborns
This study looks at how blood transfusions change stress-related substances in the blood of newborns. It might help doctors understand how transfusions affect babies in the NICU.
Graz, StyriaAges 5 minutes–5 months - NCT07668934Enrolling by invitationPhase 4
TAF for early and middle pregnancy with chronic hepatitis B
This trial tests a hepatitis B medicine called TAF in pregnant women who need antiviral treatment. It helps protect both mom and baby from complications of the virus.
Guangzhou, GuangdongAges 20–40 - NCT07662889Enrolling by invitation
Comparing two types of dialysis for kidney failure
This trial compares a newer type of dialysis called hemodiafiltration with standard hemodialysis to see if it improves certain health measures in people with end-stage kidney disease. It may help determine which method works better for long-term treatment.
Lahore, Punjab ProvinceAges 18–70 - NCT07656090Enrolling by invitationEarly Phase 1
Testing IDOV-Immune for advanced solid tumors
This trial tests an investigational drug called IDOV-Immune for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and effective.
Beijing, Beijing MunicipalityAges 18–75 - NCT07640139Enrolling by invitation
Study of Weight-Loss Medications' Health and Cost Effects
This research study looks at how obesity medications affect people's health outcomes and healthcare costs. Researchers will track employees and their family members covered by participating Indiana employers to understand whether these medications help improve conditions like diabetes and heart health.
Indianapolis, IndianaAges 18–64 - NCT07640074Enrolling by invitation
Coconut-based filling material for children's cavities
This study tests a new filling material made from coconut to repair cavities in children's primary (baby) teeth. Researchers want to see how well this material works compared to traditional fillings.
IslamabadAges 5–9 - NCT07639788Enrolling by invitation
Does classical music help with robotic surgery training?
This study tests whether listening to classical music while practicing robotic surgery on a simulator helps you perform better. Researchers will compare your performance with and without music to see if it makes a difference in your skills.
Vienna, State of ViennaAges 18–65 - NCT07629284Enrolling by invitation
Home-Based Breathing Therapy for Children With Duchenne Muscular Dystrophy
This study tests whether children with Duchenne muscular dystrophy (a genetic muscle-weakening condition) can improve their breathing strength and function by doing guided exercises at home using video calls with a therapist. The goal is to help children breathe better and stay as active as possible.
Seoul, SeoulAges 3 years+ - NCT07625488Enrolling by invitation
Heart Disease Risk Follow-up Study for Former Athletes
This study follows up with people who participated in a heart-health study between 2012 and 2014. Researchers will use heart imaging and exercise tests to check your cardiovascular health and learn more about heart disease risk in athletes.
NijmegenAges 45 years+ - NCT07616817Enrolling by invitation
Expert Panel Study on Ultrasound Assessment of Septic Shock
This study gathers expert opinions from critical care doctors and specialists around the world who use bedside ultrasound (a portable imaging tool) to diagnose and categorize septic shock (a life-threatening infection condition). The goal is to develop standardized approaches to identifying different types of septic shock using ultrasound.
Albany, New YorkAges Any age
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,440 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.